Skip to main content
NIH funding notice PAR-18-181

Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33 Clinical Trial Optional)

Closed on January 7, 2020.

Posted
November 1, 2017
Close date
January 7, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $329,769 in first-year total cost, median $329,769.

Most frequent study sections

  1. Basic Neuroscience of Aging Study Section[NIA-N]1

Most frequent institutions

  1. WILLIAM BEAUMONT HOSPITAL RESEARCH INST1
Competing awards under PAR-18-181 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline?1R21AG067083-01CUNNINGHAM, EMMA LOUISEGRAHAM, STEWART FGREEN, BRIANWILLIAM BEAUMONT HOSPITAL RESEARCH INST, MI$329,769NIA

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.